A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids

Irish Journal of Medical Science

Volumn 166, Issue 4, 1997, Pages 249-252

  Tormey, V J ^a   Faul, J ^a   Leonard, C ^a   Lennon, A ^a   Burke, C M ^a  

^a Royal College of Surgeons in Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HISTAMINE; OXITROPIUM BROMIDE; PLACEBO; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; MALE; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SPIROMETRY;

EID: 0030772872     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02944245     Document Type: Article

References (14)

1. Sears, M. R., Taylor, D. R., Print, C. G. et al. Regular inhaled beta agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396.
2. Spitzer, W. O., Suissa, S., Ernst, P. et al. The use of beta agonists and the risk of death or near death from asthma. New. Engl. J. Med. 1992; 326: 501-506.
3. Crane, J., Pearce, N., Flatt, A. et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case control study. Lancet 1989; 1: 917-922.
4. Page, C., Costello, J. Controversies in respiratory medicine: regular inhaled beta agonists - clear clinical benefit or a hazard to health? Why beta agonists should not be used regularly. Respir. Med. 1992; 86: 477-479.
5. Taylor, D. R., Sears, M. R., Herbison, G. P. et al. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993; 48: 134-138.
6. Vathenen, A. S., Knox, A. J., Higgins, B. G., Britton, J. R., Tattersfield, A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554-558.
7. Cockroft, D. W., Murdock, K. Y. Effects of inhaled salbutamol, sodium cromoglycate and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 1987; 79: 734-740.
8. O'Connor, B. J., Aikman, S. L., Barnes, P. J. Tolerance to the non bronchodilator effects of inhaled 132-agonists in asthma. New Engl. J. Med. 1992; 327: 1204-1208.
9. Cockroft, D. W., McParland, C. P., Britto, S. A., Swystun, V. A., Rutherford, B. C. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342: 833-837.
10. Krann, J., Koeter, G. H., Mark, Th. W. van der, Sluiter, H. J., Vries, K. de. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 1985; 76: 628-636.
11. Cheung, D., Timmers, M. C., Zwindermann, A. H., Bel, E. H. Dijkman, J. H., Sterk, P. J. Longterm effects on long-acting 132 adrenoreceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. New Engl. J. Med. 1992; 1327:1198-1203.
12. National Asthma Education Program. Guidelines for the diagnosis and management of asthma. Bethesda, Md.: Department of Health and Human Services, 1991. (NIH publication no. 91-3042).
13. Guidelines on the management of asthma. 1 - Management of chronic asthma in adults. Statement by the British Thoracic Society. Thorax 1993; 48: S3-S12.
14. Chapman, K. R., Kesten, S., Szalai, J. P. Regular vs. as-needed inhaled salbutamol in asthma control. Lancet 1994; 343: 1379-1382.